Position in RDY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$623,250
-$8,550 QoQ
Shares Held
45,000
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Amundi holds $607,665,967 across 23 Drug Manufacturers - Specialty & Generic names. RDY ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,166,361 | $374,295,531 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
147,599 | $87,523,254 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,765,686 | $53,182,461 | |
| 4 | VTRS |
Viatris Inc
|
3,407,023 | $46,028,880 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
203,637 | $26,827,137 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
78,456 | $5,950,886 | |
| 7 | HCM |
HUTCHMED (China) Ltd
|
232,246 | $3,474,399 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
98,313 | $2,352,630 |
All Filings in RDY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $623,250 | 45,000 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $631,800 | 45,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,376,331 | 98,450 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,479,703 | 98,450 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,298,555 | 98,450 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,554,525 | 98,450 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,190,955 | 14,990 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,148,411 | 15,073 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,168,831 | 15,935 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,759,140 | 97,142 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,572,087 | 38,464 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,827,918 | 28,964 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,529,367 | 26,864 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,866,312 | 36,064 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,243,807 | 23,764 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,404,490 | 61,464 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $2,712,044 | 48,664 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,340,280 | 66,355 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,514,426 | 84,655 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,870,404 | 66,255 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||